Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. Academic Article uri icon

Overview

abstract

  • We believe the proposed model is appropriate to our current state of knowledge and recognize that FDA regulations will evolved as the field evolves. We thank you for the opportunity to work with FDA as its regulatory strategy is developed in the near future.

publication date

  • August 1, 1997

Research

keywords

  • Accreditation
  • Hematopoietic Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 0030800526

Digital Object Identifier (DOI)

  • 10.1089/scd.1.1997.6.287

PubMed ID

  • 9377066

Additional Document Info

volume

  • 6

issue

  • 4